|
Laxman Pai, Opalesque Asia: Virginia-based venture capital firm Sands Capital has raised a whopping $560 million for its second life sciences fund.
The fund, Sands Capital Life Sciences Pulse Fund II LP, follows an earlier fund from 2018 focused on life sciences. Together the Pulse Strategy funds have $950 million in assets under management.
According to a press release from the active, long-term investor in leading innovative businesses globally, the Pulse II fund will make investments in private therapeutics, diagnostics, and life sciences tools, with a mission to "help transform how diseases are defined, diagnosed and treated".
"We believe the life sciences sector is in the early stages of a scientific and technological revolution that is generating and will generate for decades to come, tremendous value for patients and society," Stephen Zachary, managing partner of Sands Capital, said.
Since launching Pulse I in 2018, the Pulse Strategy has invested in 20 businesses while continuing to build its investment, operations, and client relations teams. The team comprises dedicated partners and analysts with the ability to leverage the resources and capabilities of the entire firm to execute its strategy, the release said.
As of June 30, 2021, Sands Capital managed over $80 billion in public and private investments and invested more than $9 billion globally in life sciences and health care companies across all strategies, both public and private, said the s...................... To view our full article Click here
|
RSS
